Sean E. Harper

Sean E. Harper

Executive Vice President, Research and DevelopmentatAmgen· In the 2012 proxy

Pay in FY2012Amgen stock +36.8% the same year

Sean E. Harper was paid $6.1M in FY2012 (Dec). Amgen stock rose 36.8% that year.

Pay$100 in the stock at the end of FY11 → $137
Pay is from the Summary Compensation Table of each Amgen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AmgenPublic company · 14 yr
    • Executive Vice President, Research and Development2012 – Present · 14 yrStock in role +826%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?